Related Experiment Videos
Type I diabetes and insulin therapy
1University of Washington Diabetes Care Center, Seattle.
The Nursing Clinics of North America
|March 1, 1993
Summary
Intensive insulin therapy, a comprehensive diabetes management program, involves multiple insulin regimens. Understanding pharmacokinetic factors like absorption differences and injection site effects is crucial for effective type 1 diabetes treatment.
Area of Science:
- Endocrinology
- Pharmacology
- Diabetes Management
Background:
- Intensive insulin therapy is a cornerstone of diabetes management.
- It involves complex insulin regimens, requiring careful consideration of pharmacokinetic properties.
Purpose of the Study:
- To review the pharmacokinetic considerations essential for prescribing insulin.
- To discuss the advantages and disadvantages of various insulin regimens for type 1 diabetes.
- To highlight the potential benefits of Continuous Subcutaneous Insulin Infusion (CSII).
Main Methods:
- Literature review of pharmacokinetic issues related to insulin therapy.
- Analysis of different insulin regimens, including traditional multiple injections and CSII.
- Discussion of factors influencing insulin absorption.
Main Results:
- Key pharmacokinetic factors influencing insulin absorption include insulin type (animal vs. human), intraindividual variability, injection site, and lag time.
- Physiologic insulin regimens are recommended for type 1 diabetes.
- Continuous Subcutaneous Insulin Infusion (CSII) offers theoretical advantages for many patients.
Conclusions:
- Effective intensive insulin therapy requires a thorough understanding of insulin pharmacokinetics.
- Healthcare professionals, particularly nurse specialists, must be knowledgeable about insulin regimens and diabetes algorithms.
- Individualized treatment plans considering patient-specific factors are essential for optimal diabetes control.